Navigation Links
Health Experts and Families Encourage Annual Childhood Flu Vaccination to Reduce Flu-Related Illnesses and Deaths in Children
Date:11/27/2007

More than 300 children have died from influenza over the past four flu seasons alone. During the 2006-2007 flu season, of the patients for whom flu vaccination status is known, 94 percent of the children who died had not been vaccinated against the flu.

"Today we are strongly encouraging all parents to vaccinate their children against the flu," said Richard Kanowitz, president of Families Fighting Flu. Kanowitz's four-year-old daughter, Amanda, died suddenly in March 2004 from influenza; Amanda had not been vaccinated against the flu. "Before our daughter died, we had no idea that healthy children could die from the flu -- a virus that may be avoided with a simple annual vaccination. We sincerely hope that Children's Flu Vaccination Day will serve to educate parents about the critical importance of annual flu vaccination in children, and motivate them to get their children vaccinated as soon as possible. A simple shot could very well save your child's life."

About Influenza

Influenza, or "the flu," is a highly contagious viral infection of the respiratory tract (nose, throat and lungs). The flu virus tends to spread from November to April, with most cases occurring between December and March. The flu is often confused with the common cold, but flu symptoms tend to develop quickly (usually one to four days after a person is exposed to the flu virus) and are usually more severe than the typical sneezing and congestion associated with a cold. Influenza is often accompanied with fever, headache, extreme tiredness, dry cough, sore throat, runny or stuffy nose, and muscle aches. Nausea, vomiting and diarrhea are also common symptoms in children. A person infected with the flu virus will typically suffer from the illness for approximately seven to 10 days, with five to six days of limited activity and about three days of bed rest.

Who Should Get Vaccinated?

Any child older than 6 months old can get vaccinated against influenza. The
'/>"/>

SOURCE Families Fighting Flu, Inc.
Copyright©2007 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Baxter Awarded Pandemic Advanced Supply Contract from the Department of Health
3. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
4. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
5. Tone Deafness Explained, from the Harvard Health Letter
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Opko Health Doses First Patient in Phase 3 COBALT Trial of Bevasiranib for the Treatment of AMD
8. ViroPharma to Present at Three Upcoming Healthcare Conferences
9. AIDS Healthcare Foundation Names Homayoon Khanlou, M.D. as its Chief of Medicine, U.S.
10. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
11. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/17/2010)... states to settle a whistleblower lawsuit that exposed an alleged kickback scheme by the pharmaceutical company to boost its sales of Kadian, a prescription painkiller. , ... ... ... ... "Patients need to know their doctors are prescribing drugs ...
(Date:3/17/2010)... 12 month follow up data from real world patients demonstrated long term clinical efficacy of the company,s Genous Bio-engineered R stent. , ... ... ... ... Margo Klomp , M.D., of the Academic Medical Center (AMC) in ...
(Date:3/17/2010)... DIEGO , March 17 ... announced that it has initiated a pivotal Phase ... controlled-release formulation of hydrocodone without acetaminophen.  ZX002 is ... severe pain in individuals who require around-the-clock opioid ... the most widely prescribed drug in the ...
Breaking Medicine Technology:Whistleblower Kickback Case Against Alpharma Results In $42.5 Million Recovery for U.S. and States 2Whistleblower Kickback Case Against Alpharma Results In $42.5 Million Recovery for U.S. and States 3Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 2Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 3Data Presented at ACC/i2 Summit Demonstrate Impressive Long Term Clinical Outcomes in Real World Patients Treated with OrbusNeich's Genous(TM) Bio-engineered R stent(TM) 4Zogenix Initiates Pivotal Phase 3 Clinical Trial for Novel Formulation of Oral Controlled-Release Hydrocodone 2Zogenix Initiates Pivotal Phase 3 Clinical Trial for Novel Formulation of Oral Controlled-Release Hydrocodone 3Zogenix Initiates Pivotal Phase 3 Clinical Trial for Novel Formulation of Oral Controlled-Release Hydrocodone 4The Secret of Happiness 49884 1The Secret of Happiness 49884 2The Secret of Happiness 49884 3First Coast Medicare to Provide Case by Case Reimbursement for the Renessa 28R 29 Treatment for Incontinence in Women 49879 1First Coast Medicare to Provide Case by Case Reimbursement for the Renessa 28R 29 Treatment for Incontinence in Women 49879 2First Coast Medicare to Provide Case by Case Reimbursement for the Renessa 28R 29 Treatment for Incontinence in Women 49879 3Mercy Health Plans Launches MercyOne Connect 28TM 29 49874 1Mercy Health Plans Launches MercyOne Connect 28TM 29 49874 2
... VRUS ), Roche (SWX: ROG) and InterMune, Inc. ... have been dosed in an innovative clinical,trial in patients ... (run in centers in Australia and New Zealand) is ... molecules in the absence,of interferon., The initial study ...
... NOVATO, Calif., Nov. 10 Raptor,Pharmaceuticals Corp. ... today announced that the Company has entered ... d,Angers ("CHU d,Angers") of France to,evaluate Raptor,s ... Phase II clinical trial in patients with ...
Other Medicine Technology:Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 2Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 3Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 4Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C 5Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 2Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 3Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 4Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 5Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire d'Angers for Phase II Clinical Trial in Huntington's Disease 6
(Date:3/17/2010)... sepsis, and other potentially deadly infections long has focused ... But new research from the University of Utah and ... overeager inflammatory response to infection may help save more ... in Science Translational Medicine , researchers led by ... professor of internal medicine and director of the Molecular ...
(Date:3/17/2010)... March 17 Marianjoy Rehabilitation ... Planning, John Brady , DHA, has been ... Persons with Disabilities Task Force. The Task Force ... to determine what changes, recommendations, and innovations may ... for persons with disabilities. These recommendations will then ...
(Date:3/17/2010)... -- The National Association of Professional Insurance Agents (PIA) has named Louisiana Congressman Charlie Melancon its 2010 Legislator of the ... ... , ... ... ...
(Date:3/17/2010)... -- City Harvest Food Council members and chefs ... Caminos), Lou Elrose (Wildwood Barbeque), Ivan ... Green Table), and Jorge Collazo (SchoolFood executive ... Tuesday March 16, 2010 , for lunch to ... Nutrition Act with priorities outlined by the NYC Alliance ...
(Date:3/17/2010)... of cancer treatment, skin care may seem like a ... Wilmot Cancer Center knew that skin issues were a ... therapy, and through research she discovered that routine advice ... , Her findings, which have been published in the ... change locally and across the country. , "We,ve had ...
Breaking Medicine News(10 mins):Health News:Targeting blood vessels, immune system may offer way to stop infection-caused inflammation 2Health News:Targeting blood vessels, immune system may offer way to stop infection-caused inflammation 3Health News:Marianjoy Vice President Named to Illinois' Disabilities Task Force 2Health News:Professional Insurance Agents Name Rep. Charlie Melancon 2010 Legislator of the Year 2Health News:Professional Insurance Agents Name Rep. Charlie Melancon 2010 Legislator of the Year 3Health News:Professional Insurance Agents Name Rep. Charlie Melancon 2010 Legislator of the Year 4Health News:City Harvest Food Council Chefs Meet With Harlem Students For Lunch & Travel to Washington to Ask Congress to Invest in Child Nutrition 2Health News:City Harvest Food Council Chefs Meet With Harlem Students For Lunch & Travel to Washington to Ask Congress to Invest in Child Nutrition 3Health News:City Harvest Food Council Chefs Meet With Harlem Students For Lunch & Travel to Washington to Ask Congress to Invest in Child Nutrition 4Health News:Nurses' research settles a common cancer concern: Skin care 2Health News:Nurses' research settles a common cancer concern: Skin care 3
... theory for how delusions arise and why they persist. ... an in-depth analysis of patients with certain delusions and ... the frontal lobe and right hemisphere of the human ... the right hemisphere, leads to the over compensation by ...
... Directors,of The Procter & Gamble Company (NYSE: PG ... on the Common Stock and on the Series A and,Series ... payable on,or after February 17, 2009 to shareholders of record ... The company has been paying dividends without ...
... 13 Born no larger than a ballpoint pen at ... been named the 2009 National Ambassador for the March of ... Leesburg, Virginia, was born very early at 25 weeks, weighing ... given only a 5 percent chance of survival. During her ...
... most states neglect preventing tobacco-caused illness , , TUESDAY, Jan. ... the U.S. government consistently failing grades for not protecting ... the American Lung Association,s State of Tobacco Control ... states failed to enact critical policy measures, such as ...
... Blood Drain NEW YORK, Jan. 13 New York ... York City, Long Island, Hudson Valley and New Jersey) ... Hospital demand for blood (needed for emergency care and ... blood donation have been below forecast. Blood supplies ...
... to patients and medical work to qualified employees. In ... Neeltje van den Berg and coauthors from Greifswald and ... edition of Deutsches rzteblatt International ( Dtsch ... in the age structure in Germany has had major ...
Other Medicine News:Health News:Delusions associated with consistent pattern of brain injury 2Health News:Delusions associated with consistent pattern of brain injury 3Health News:Micro-Preemie Survives to Become March of Dimes 2009 National Ambassador 2Health News:Micro-Preemie Survives to Become March of Dimes 2009 National Ambassador 3Health News:U.S. Flunks on Tobacco Control Report Card 2Health News:U.S. Flunks on Tobacco Control Report Card 3Health News:U.S. Flunks on Tobacco Control Report Card 4Health News:Blood Emergency: Blood Supply Tips Into Danger Zone 2Health News:Blood Emergency: Blood Supply Tips Into Danger Zone 3Health News:Blood Emergency: Blood Supply Tips Into Danger Zone 4Health News:Blood Emergency: Blood Supply Tips Into Danger Zone 5
QIAvac 96 is designed for efficient processing of QIAGEN 96-well plates....
Holder for QIAGEN 96-well plates, for use with QIAvac 96;...
For monitoring vacuum pressure, suitable for use with all QIAvac manifolds;...
DNA/RNA preparation in 8-multi channels...
Medicine Products: